Skip to main content
Uptal Patel, MD, Nephrology, Durham, NC

UptalDPatelMD

Nephrology Durham, NC

Acute Renal Failure, Hypertension, Kidney & Pancreas Transplantation

Associate Professor, Medicine, Duke University School of Medicine

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile

Already have an account?

  • Office

    4101 N Roxboro St
    Durham, NC 27704
    Phone+1 919-684-8111

Education & Training

  • University of Michigan
    University of MichiganFellowship, Nephrology, 2003 - 2005
  • University of Michigan
    University of MichiganFellowship, Pediatric Nephrology, 2001 - 2003
  • University of Michigan
    University of MichiganResidency, Internal Medicine/Pediatrics, 1997 - 2001
  • University of California San Francisco School of Medicine
    University of California San Francisco School of MedicineClass of 1997

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2005 - 2018

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Clinical Research in Nephrology: Trials, Trends, and Tools 
    American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/9/2019

Press Mentions

  • Kidney Disease Rates Have Stabilized in U.S
    Kidney Disease Rates Have Stabilized in U.SNovember 7th, 2015
  • New Strategies for Combatting Chronic Kidney Disease, Other Long-Term Conditions
    New Strategies for Combatting Chronic Kidney Disease, Other Long-Term ConditionsJune 25th, 2015
  • Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)
    Felzartamab Granted Breakthrough Therapy Designation by U.S. Food and Drug Administration (FDA) for Primary Membranous Nephropathy (PMN)November 3rd, 2023
  • Join now to see all

Grant Support

  • Barriers To Optimal Cardiovascular Medication Use In Diabetes And Renal DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010